Liu S - Search Results

1

Identification of an HLA-A*11:01-restricted neoepitope of mutant PIK3CA and its specific T cell receptors for cancer immunotherapy targeting hotspot driver mutations.

Shen M, Chen S, Han X, Hao Y, Wang J, Li L, Chen T, Wang B, Zou L, Zhang T, Zhang W, Han X, Wang W, Yu H, Li K, Liu S, Jin A. Shen M, et al. Among authors: liu s. Cancer Immunol Immunother. 2024 Jun 4;73(8):150. doi: 10.1007/s00262-024-03729-y. Cancer Immunol Immunother. 2024. PMID: 38832948 Free PMC article.

2

Lysophosphatidic Acid Receptor 6 (LPAR6) Expression and Prospective Signaling Pathway Analysis in Breast Cancer.

Tao K, Guo S, Chen R, Yang C, Jian L, Yu H, Liu S. Tao K, et al. Among authors: liu s. Mol Diagn Ther. 2019 Feb;23(1):127-138. doi: 10.1007/s40291-019-00384-3. Mol Diagn Ther. 2019. PMID: 30694446

3

Sulfasalazine‑induced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor.

Yu H, Yang C, Jian L, Guo S, Chen R, Li K, Qu F, Tao K, Fu Y, Luo F, Liu S. Yu H, et al. Among authors: liu s. Oncol Rep. 2019 Aug;42(2):826-838. doi: 10.3892/or.2019.7189. Epub 2019 Jun 6. Oncol Rep. 2019. PMID: 31173262

4

CXCL1 stimulates migration and invasion in ER‑negative breast cancer cells via activation of the ERK/MMP2/9 signaling axis.

Yang C, Yu H, Chen R, Tao K, Jian L, Peng M, Li X, Liu M, Liu S. Yang C, et al. Among authors: liu m, liu s. Int J Oncol. 2019 Sep;55(3):684-696. doi: 10.3892/ijo.2019.4840. Epub 2019 Jul 15. Int J Oncol. 2019. PMID: 31322183 Free PMC article.

5

Low pretreatment lymphocyte/monocyte ratio is associated with the better efficacy of neoadjuvant chemotherapy in breast cancer patients.

Peng Y, Chen R, Qu F, Ye Y, Fu Y, Tang Z, Wang Y, Zong B, Yu H, Luo F, Liu S. Peng Y, et al. Among authors: liu s. Cancer Biol Ther. 2020;21(2):189-196. doi: 10.1080/15384047.2019.1680057. Epub 2019 Nov 4. Cancer Biol Ther. 2020. PMID: 31684807 Free PMC article.

6

Novel Breast-Specific Long Non-coding RNA LINC00993 Acts as a Tumor Suppressor in Triple-Negative Breast Cancer.

Guo S, Jian L, Tao K, Chen C, Yu H, Liu S. Guo S, et al. Among authors: liu s. Front Oncol. 2019 Dec 17;9:1325. doi: 10.3389/fonc.2019.01325. eCollection 2019. Front Oncol. 2019. PMID: 31921620 Free PMC article.

7

Although c‑MYC contributes to tamoxifen resistance, it improves cisplatin sensitivity in ER‑positive breast cancer.

Chen R, Guo S, Yang C, Sun L, Zong B, Li K, Liu L, Tu G, Liu M, Liu S. Chen R, et al. Among authors: liu m, liu l, liu s. Int J Oncol. 2020 Apr;56(4):932-944. doi: 10.3892/ijo.2020.4987. Epub 2020 Feb 14. Int J Oncol. 2020. PMID: 32319562 Free PMC article.

8

Assessment of the Predictive Role of Serum Lipid Profiles in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.

Qu F, Chen R, Peng Y, Ye Y, Tang Z, Wang Y, Zong B, Yu H, Liu S. Qu F, et al. Among authors: liu s. J Breast Cancer. 2020 Jun;23(3):246-258. doi: 10.4048/jbc.2020.23.e32. J Breast Cancer. 2020. PMID: 32595987 Free PMC article.

9

AGR3 promotes estrogen receptor-positive breast cancer cell proliferation in an estrogen-dependent manner.

Jian L, Xie J, Guo S, Yu H, Chen R, Tao K, Yang C, Li K, Liu S. Jian L, et al. Among authors: liu s. Oncol Lett. 2020 Aug;20(2):1441-1451. doi: 10.3892/ol.2020.11683. Epub 2020 May 28. Oncol Lett. 2020. PMID: 32724387 Free PMC article.

10

Prognostic value of programmed cell death ligand-1 expression in breast cancer: A meta-analysis.

Zhang Y, Tian J, Qu C, Tang Z, Wang Y, Li K, Yang Y, Liu S. Zhang Y, et al. Among authors: liu s. Medicine (Baltimore). 2020 Dec 4;99(49):e23359. doi: 10.1097/MD.0000000000023359. Medicine (Baltimore). 2020. PMID: 33285715 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77,546 results

Search Page

Filters